HCW Biologics (HCWB) Shares Outstanding (2020 - 2025)
HCW Biologics' (HCWB) quarterly Shares Outstanding (Entity) came in at $349617.0 in Q4 2025, up 116.3% YoY from $161638.0 in Q4 2024, and down 19.98% on a QoQ basis from $436934.0 in Q3 2025.
HCW Biologics (HCWB) Shares Outstanding (2020 - 2025) Analysis & Trends
HCW Biologics (HCWB) has 6 years of Shares Outstanding (Entity) data on file, last reported at $349617.0 in Q4 2025.
- Quarterly Shares Outstanding (Entity) rose 116.3% year-over-year to $349617.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $349617.0 (up 116.3% YoY) and the FY2025 annual result came in at $349617.0, up 116.3% from the prior year.
- Shares Outstanding (Entity) slipped to $349617.0 in Q4 2025, from $436934.0 in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $7.5 million in Q1 2025 to a low of $20166.0 in Q1 2021.
- A 5-year average of $532248.0 and a median of $149696.0 in 2023 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) grew 0.25% — and 2025, when it soared 4652.01%.
- Tracing HCWB's Shares Outstanding (Entity) over 5 years: stood at $78212.0 in 2021, then surged by 91.13% to $149485.0 in 2022, then advanced by 0.41% to $150105.0 in 2023, then rose by 7.68% to $161638.0 in 2024, then jumped by 116.3% to $349617.0 in 2025.
- The last three Shares Outstanding (Entity) figures came in at $349617.0 (Q4 2025), $436934.0 (Q3 2025), and $296686.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 133.61 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 217.35 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 445.06 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 241.70 Mn |
| 10 | HCW Biologics | 2.93 Mn | 2.19 Mn | -93,887.00 | 1.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 349,617.00 |
| Sep 30, 2025 | 376,678.00 |
| Jun 30, 2025 | 296,686.00 |
| Mar 31, 2025 | 7.45 Mn |
| Dec 31, 2024 | 161,638.00 |
| Sep 30, 2024 | 157,597.00 |
| Jun 30, 2024 | 157,597.00 |
| Mar 31, 2024 | 155,098.00 |
| Dec 31, 2023 | 149,706.00 |
| Sep 30, 2023 | 149,696.00 |
| Jun 30, 2023 | 149,628.00 |
| Mar 31, 2023 | 149,516.00 |
| Dec 31, 2022 | 149,259.00 |
| Sep 30, 2022 | 149,313.00 |
| Jun 30, 2022 | 149,227.00 |
| Mar 31, 2022 | 149,075.00 |
| Dec 31, 2021 | 78,212.00 |
| Sep 30, 2021 | 123,218.00 |
| Jun 30, 2021 | 20,505.00 |
| Mar 31, 2021 | 20,166.00 |